First, one SWEET registry study examined use of diabetes technology (insulin pumps, continuous glucose monitors) across 101 SWEET centers, showing that > 60% of the 25,654 pediatric T1D patients used at least one technological component for diabetes management [33]. This evidence concerns the gene INS and diabetes mellitus.